Griffin Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,150
| Closed | -$310K | – | 243 |
|
|
2025
Q3 | $310K | Sell |
2,150
-1,015
| -32% | -$139K | 0.03% | 178 |
|
|
2025
Q2 | $400K | Hold |
3,165
| – | – | 0.05% | 166 |
|
|
2025
Q1 | $405K | Hold |
3,165
| – | – | 0.05% | 158 |
|
|
2024
Q4 | $418K | Hold |
3,165
| – | – | 0.05% | 168 |
|
|
2024
Q3 | $461K | Hold |
3,165
| – | – | 0.05% | 163 |
|
|
2024
Q2 | $434K | Hold |
3,165
| – | – | 0.05% | 165 |
|
|
2024
Q1 | $434K | Hold |
3,165
| – | – | 0.05% | 170 |
|
|
2023
Q4 | $430K | Hold |
3,165
| – | – | 0.05% | 167 |
|
|
2023
Q3 | $387K | Hold |
3,165
| – | – | 0.06% | 168 |
|
|
2023
Q2 | $402K | Hold |
3,165
| – | – | 0.05% | 169 |
|
|
2023
Q1 | $409K | Hold |
3,165
| – | – | 0.06% | 170 |
|
|
2022
Q4 | $416K | Hold |
3,165
| – | – | 0.06% | 164 |
|
|
2022
Q3 | $370K | Hold |
3,165
| – | – | 0.06% | 163 |
|
|
2022
Q2 | $372K | Hold |
3,165
| – | – | 0.06% | 170 |
|
|
2022
Q1 | $412K | Hold |
3,165
| – | – | 0.05% | 169 |
|
|
2021
Q4 | $483K | Hold |
3,165
| – | – | 0.06% | 172 |
|
|
2021
Q3 | $512K | Hold |
3,165
| – | – | 0.07% | 173 |
|
|
2021
Q2 | $518K | Hold |
3,165
| – | – | 0.06% | 178 |
|
|
2021
Q1 | $477K | Hold |
3,165
| – | – | 0.06% | 175 |
|
|
2020
Q4 | $479K | Hold |
3,165
| – | – | 0.06% | 162 |
|
|
2020
Q3 | $429K | Hold |
3,165
| – | – | 0.07% | 158 |
|
|
2020
Q2 | $433K | Hold |
3,165
| – | – | 0.07% | 157 |
|
|
2020
Q1 | $341K | Hold |
3,165
| – | – | 0.06% | 157 |
|
|
2019
Q4 | $381K | Hold |
3,165
| – | – | 0.05% | 170 |
|
|
2019
Q3 | $315K | Hold |
3,165
| – | – | 0.05% | 182 |
|
|
2019
Q2 | $345K | Sell |
3,165
-195
| -6% | -$20.7K | 0.04% | 198 |
|
|
2019
Q1 | $376K | Hold |
3,360
| – | – | 0.05% | 192 |
|
|
2018
Q4 | $324K | Sell |
3,360
-110
| -3% | -$11.7K | 0.05% | 185 |
|
|
2018
Q3 | $423K | Buy |
3,470
+305
| +10% | +$35.9K | 0.06% | 186 |
|
|
2018
Q2 | $348K | Hold |
3,165
| – | – | 0.06% | 171 |
|
|
2018
Q1 | $338K | Hold |
3,165
| – | – | 0.06% | 176 |
|
|
2017
Q4 | $338K | Hold |
3,165
| – | – | 0.06% | 174 |
|
|
2017
Q3 | $352K | Buy |
+3,165
| New | +$338K | 0.06% | 177 |
|
Other funds holding IBB
Griffin Asset Management's IBB Position: Q4 2025 in Review
Griffin Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 2,150 shares — an estimated $310K sold.
Griffin Asset Management first reported a position in IBB in Q3 2017 and held it in 33 quarters. The position peaked at $518K in Q2 2021. 959 funds tracked by Wall St. Rank hold IBB as of Q4 2025.
- Griffin Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
- Griffin Asset Management sold 2,150 iShares Biotechnology ETF shares in Q4 2025, an estimated $310K.
- Griffin Asset Management first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 33 quarters.
- Griffin Asset Management's iShares Biotechnology ETF position peaked at $518K in Q2 2021.
- 959 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.
Based on Griffin Asset Management's 13F filing for Q4 2025, filed 6 Feb 2026.